The cytotoxic drug melphalan activates respiratory epithelial cells in vitro . Source: Eur Respir J 2002; 20: Suppl. 38, 282s Year: 2002
Interplaying between Gamma-H2AX and autophagy in A549 cells treated with cisplatin and etoposide Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
Effects of Cisplatin and Pemetrexed on the cell viability and cell adhesion of benign mesothelial and mesothelioma cells. Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells Source: International Congress 2017 – Translational studies of lung disease Year: 2017
The effect of Taxane anticancer drugs on bronchiolar ciliary activity in human airway cultured cells Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020
Roles of volume-sensitive Cl- channel in cisplatin resistance of human lung adenocarcinoma cells Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
2-Deoxy-glucose synergizes with Cisplatin and Pemetrexed chemotherapeutics to reduce cell migration of mesothelioma cells Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019
Engineered nanoparticles induce apoptosis of human bronchial epithelial cells Source: Annual Congress 2011 - Lung cell biology Year: 2011
Pepsins are cytotoxic to bronchial epithelial cells Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007
Conditioned medium from human mesenchymal stem cells restores both amiloride sensitive sodium transport and epithelial permeability to protein across alveolar epithelial cell monolayers in an in vitro model of alveolar injury Source: Annual Congress 2011 - Barrier functions in sepsis and acute lung injury Year: 2011
A comparison of the cytotoxicity of different coals in lung epithelial cells Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020
Pegylated liposomal doxorubicin compared with traditional doxorubicin in combination chemo-radiotherapy for small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002
A comparison between the toxic side effects of adriamycin, cyclophosphamide, and etoposide (ACE) and carboplatin with etoposide (CbE) in the treatment of small cell lung cancer (SCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003
Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung Year: 2009
The effects of bortezomib on endothelial progenitor cells Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008
Double high-dose ifosfamide, carboplatin and etoposide (ICE) therapy for small cell lung cancer (SCLC) with peripheral blood stem cell transplantation (PBSCT) Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004
First line treatment with gemcitabine plus cisplatine in non-small cell lung cancer: a comparison with etoposide plus cisplatin Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005
A study of paclitaxel in two dose combinations with carboplatin in the treatment of small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001
Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015